Page last updated: 2024-10-21

3-methoxytyramine and Movement Disorders

3-methoxytyramine has been researched along with Movement Disorders in 1 studies

3-methoxytyramine: RN given refers to parent cpd
3-methoxytyramine : A monomethoxybenzene that is dopamine in which the hydroxy group at position 3 is replaced by a methoxy group. It is a metabolite of the neurotransmitter dopamine and considered a potential biomarker of pheochromocytomas and paragangliomas.

Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Willard, AM1
Bouchard, RS1
Gittis, AH1

Other Studies

1 other study available for 3-methoxytyramine and Movement Disorders

ArticleYear
Differential degradation of motor deficits during gradual dopamine depletion with 6-hydroxydopamine in mice.
    Neuroscience, 2015, Aug-20, Volume: 301

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Agents; Animals; Chromatography, High Pressure Liquid; Di

2015